American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Pfizer
PFE
|
$462M |
| 2 |
Colgate-Palmolive
CL
|
$372M |
| 3 |
Microsoft
MSFT
|
$331M |
| 4 |
Fidelity National Information Services
FIS
|
$298M |
| 5 |
Charles Schwab
SCHW
|
$232M |
Top Sells
| 1 |
WP
Worldpay, Inc.
WP
|
$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
$268M |
| 3 |
Medtronic
MDT
|
$242M |
| 4 |
Intercontinental Exchange
ICE
|
$203M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
$187M |
Sector Composition
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
GDS Holdings
GDS
$6.62B
| $281M | 0.28% | 7,007,209 +652,475 | +10% | +$26.2M |
|
102
HDFC Bank
HDB
$182B
| $277M | 0.28% | 4,861,338 +2,449,221 | +102% | +$140M |
|
103
Southwest Airlines
LUV
$17.3B
| $276M | 0.28% | 5,117,803 -159,768 | -3% | -$8.63M |
|
104
Baker Hughes
BKR
$44.8B
| $274M | 0.28% | 11,830,530 +2,787,184 | +31% | +$64.7M |
|
105
Monster Beverage
MNST
$60.9B
| $273M | 0.27% | 4,702,786 -20,120 | -0.4% | -$1.17M |
|
106
Ameriprise Financial
AMP
$48.5B
| $270M | 0.27% | 1,834,674 +1,106 | +0.1% | +$163K |
|
107
ONE Gas
OGS
$4.59B
| $270M | 0.27% | 2,807,501 -53,379 | -2% | -$5.13M |
|
108
Eversource Energy
ES
$23.8B
| $269M | 0.27% | 3,149,462 -1,642,920 | -34% | -$140M |
|
109
MSC Industrial Direct
MSM
$5.02B
| $265M | 0.27% | 3,659,933 +515,682 | +16% | +$37.4M |
|
110
Genuine Parts
GPC
$19.4B
| $265M | 0.27% | 2,660,594 +965,196 | +57% | +$96.1M |
|
111
Bank of New York Mellon
BK
$74.5B
| $264M | 0.27% | 5,850,089 -2,326,409 | -28% | -$105M |
|
112
EOG Resources
EOG
$68.2B
| $263M | 0.26% | 3,539,180 -827,293 | -19% | -$61.4M |
|
113
Regeneron Pharmaceuticals
REGN
$61.5B
| $262M | 0.26% | 943,920 -88,094 | -9% | -$24.4M |
|
114
Roper Technologies
ROP
$56.6B
| $261M | 0.26% | 732,723 -211,408 | -22% | -$75.4M |
|
115
Take-Two Interactive
TTWO
$43B
| $256M | 0.26% | 2,038,934 +50,318 | +3% | +$6.31M |
|
116
Aflac
AFL
$57.2B
| $251M | 0.25% | 4,792,646 -2,688,628 | -36% | -$141M |
|
117
Stryker
SYK
$150B
| $248M | 0.25% | 1,147,920 +108,090 | +10% | +$23.4M |
|
118
Elanco Animal Health
ELAN
$9.12B
| $243M | 0.24% | 9,120,261 +1,349,274 | +17% | +$35.9M |
|
119
Bio-Rad Laboratories Class A
BIO
$8.06B
| $242M | 0.24% | 727,542 -21,260 | -3% | -$7.07M |
|
120
Verisk Analytics
VRSK
$37.5B
| $242M | 0.24% | 1,530,655 +282,418 | +23% | +$44.7M |
|
121
Berkshire Hathaway Class B
BRK.B
$1.09T
| $242M | 0.24% | 1,162,012 +369,831 | +47% | +$76.9M |
|
122
Booz Allen Hamilton
BAH
$13.4B
| $241M | 0.24% | 3,386,471 -627,736 | -16% | -$44.6M |
|
123
Burlington
BURL
$18.3B
| $240M | 0.24% | 1,201,576 -858,968 | -42% | -$172M |
|
|
TWTR
124
DELISTED
Twitter, Inc.
TWTR
| $239M | 0.24% | 5,811,659 +519,506 | +10% | +$21.4M |
|
125
CoStar Group
CSGP
$37.9B
| $238M | 0.24% | 401,496 -125,727 | -24% | -$74.6M |
|